Literature DB >> 14704127

Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis.

Ying Zhang1, Li-Jun Wu, Shin-Ichi Tashiro, Satoshi Onodera, Takashi Ikejima.   

Abstract

AIM: To study the different death pathways in human cervical cancer HeLa and melanoma A375-S2 cells initiated by evodiamine.
METHODS: Viability of evodiamine-induced HeLa and A375-S2 cells was measured by MTT assay. Apoptotic cells with condensed or fragmented nuclei were visualized by Hoechst 33258 staining. Nucleosomal DNA fragmentation was assayed by agarose gel electrophoresis. Proportion of cell death through apoptotic and necrotic pathways was determined by LDH activity-based cytotoxicity assays. Cell cycle distribution was observed by flow cytometry.
RESULTS: Evodiamine induced HeLa and A375-S2 cell death dose- and time-dependently. Caspase-3 and -8 were activated in apoptosis induced by evodiamine 15 micromol/L. However, over 24-h incubation of A375-S2 cells, evodiamine 15 micromol/L initiated necrosis related to p38 and ERK (extracellular signal-regulated kinases) activities. Evodiamine-induced HeLa cell death was preceded by an accumulation of cells at the G2/M phase of the cell cycle, but there was no significant effect of evodiamine on A375-S2 cell cycle.
CONCLUSION: Evodiamine induces caspase-3,8-dependent apoptosis in HeLa cells which is related to G2/M arrest of the cell cycle. On the other hand, in A375-S2 cells, evodiamine initiates caspase-3,8-mediated apoptosis at early stages and the induction of MAPK-mediated necrosis at later stages of cell culture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14704127

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  14 in total

1.  Evodiamine inhibits proliferation and induces apoptosis in gastric cancer cells.

Authors:  Huamei Shen; Shuai Zhao; Zhipeng Xu; Lihua Zhu; Yuehua Han; Jun Ye
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

2.  Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME.

Authors:  Hanzhang Zhu; Ke Ge; Jun Lu; Changku Jia
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-29       Impact factor: 3.000

3.  Cytotoxic effect of protic ionic liquids in HepG2 and HaCat human cells: in vitro and in silico studies.

Authors:  Bruna Varela Zanoni; Gabriela Brasil Romão; Rebecca S Andrade; Regina Maria Barretto Cicarelli; Eliane Trovatti; Bruna Galdorfini Chiari-Andrèo; Miguel Iglesias
Journal:  Toxicol Res (Camb)       Date:  2019-02-28       Impact factor: 3.524

Review 4.  Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers.

Authors:  Munmun Panda; Surya Kant Tripathi; Gokhan Zengin; Bijesh K Biswal
Journal:  Cell Biol Toxicol       Date:  2022-09-23       Impact factor: 6.819

5.  Caspase-independent apoptosis in Friend's erythroleukemia cells: role of mitochondrial ATP synthesis impairment in relocation of apoptosis-inducing factor and endonuclease G.

Authors:  Marina Comelli; Nadia Genero; Irene Mavelli
Journal:  J Bioenerg Biomembr       Date:  2009-01-29       Impact factor: 2.945

6.  Dynamic expressions of liver tissue apoptosis-related genes of Vibrio vulnificus sepsis rats and the effects of antibacterial agents.

Authors:  Zhongqiu Lu; Mengfang Li; Huan Liang; Qiaomeng Qiu; Guangtian Yang; Tieli Zhou; Guangliang Hong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

7.  Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.

Authors:  Wei-Tian Wei; Hui Chen; Zhao-Hong Wang; Zhong-Lin Ni; Hai-Bin Liu; Hong-Fei Tong; Hong-Chun Guo; Dian-Lei Liu; Sheng-Zhang Lin
Journal:  Int J Biol Sci       Date:  2011-11-05       Impact factor: 6.580

8.  Inhibitory effects of evodiamine on human osteosarcoma cell proliferation and apoptosis.

Authors:  Xiaodong Bai; Hai Meng; Lifeng Ma; Ai Guo
Journal:  Oncol Lett       Date:  2014-12-11       Impact factor: 2.967

9.  Characterization of the in Vitro Metabolic Profile of Evodiamine in Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer.

Authors:  Zhaowei Zhang; Tianzi Fang; Hongyun Zhou; Jie Yuan; Qingwang Liu
Journal:  Front Pharmacol       Date:  2018-02-22       Impact factor: 5.810

Review 10.  Pharmacological actions of multi-target-directed evodiamine.

Authors:  Hui Yu; Hongwei Jin; Wuzhuang Gong; Zhanli Wang; Huaping Liang
Journal:  Molecules       Date:  2013-01-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.